Bioceres Crop (BIOX) Fundamental Analysis: Revenue, Earnings & Valuation

5.69 / 10

Netural

Fundamental assessment scores 5.7/10 (Neutral). Strengths include Profit‑MV and Net‑income‑Revenue ratios; weaknesses are Cash‑UP and Revenue‑MV. PB‑ROE is modestly negative, current ratio is low (0.91), but interest coverage is strong (35.1). Overall, fundamentals are moderate and warrant caution.

Analysis Checks(6/10)

Revenue-MV

Value1.47

Score1/3

Weight7.53%

1M Return2.98%

Net cash flow from operating activities per share (YoY growth rate %)

Value18.91

Score1/3

Weight5.67%

1M Return2.27%

Profit-MV

Value0.66

Score3/3

Weight19.15%

1M Return6.99%

Net income-Revenue

Value-0.04

Score2/3

Weight8.29%

1M Return3.37%

PB-ROE

Value-0.92

Score2/3

Weight7.07%

1M Return2.58%

Cash-UP

Value-0.18

Score1/3

Weight-0.50%

1M Return-0.24%

Long-term debt to working capital ratio (%)

Value6.39

Score3/3

Weight16.30%

1M Return6.10%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score3/3

Weight17.16%

1M Return6.47%

Equity multiplier (DuPont analysis %)

Value2.78

Score3/3

Weight15.04%

1M Return6.00%

Current ratio

Value0.91

Score1/3

Weight4.28%

1M Return1.73%

Is BIOX fundamentally strong?

BIOX scores 5.69/10 on fundamentals and holds a Fair valuation at present. Backed by its -94.75% ROE, -82.89% net margin, -0.13 P/E ratio, 0.28 P/B ratio, and -9493.78% earnings growth, these metrics solidify its Netural investment rating.